For too long, Alzheimer’s disease has been defined by loss. We talk about who people used to be, even while they’re still here. But with disease-modifying treatments, the future of AD is beginning to change. Patients diagnosed in the early stages have the opportunity to slow progression and hold on to more of who they are today, for longer. Still Can Be tells the stories of real patients treated with LEQEMBI—the passions, pursuits, and defining parts of themselves that still remain at the center of their lives.
Excitement video for National Sales Meeting
Website
IVA and brochure assets